Subgroup analysis based on the new risk stratification
PRIMARY TUMOR
To underscore the benefits of risk stratification, we conducted an analysis of primary tumor sites and surgical outcomes across the different risk groups. Intriguingly, we observed a poorer prognosis in the retroperitoneum for the intermediate-risk group, whereas a worse prognosis was noted in the adrenal gland for the high-risk group (Fig. 